cedirogant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for cedirogant, covering 2023-11-29 to 2023-11-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis [Phase 2]